NN6 — NanoRepro AG Income Statement

0.000.00%

Last trade - 00:00

HealthcareAdventurousMicro CapHigh Flyer

Annual income statement for NanoRepro AG, fiscal year end - December 31st, EUR millions except per share, conversion factor applied.

	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	ARS	ARS	ARS	ARS	PRESS
Standards:	GAS	GAS	GAS	GAS	GAS
Status:	Final	Final	Final	Final	Preliminary
Revenue
Total Revenue	163	38.5	3.18	4.47	4.34
Cost of Revenue
Gross Profit	56.6	11.7	1.83	2.77	2.69
Selling / General / Administrative Expenses
Depreciation and Amortization
Operating Interest Expense / Income
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses	124	42.9	8.52	8.09	6.76
Operating Profit	38.8	-4.37	-5.34	-3.62	-2.42
Total Net Non Operating Interest Income / Expense
Total Net Non Operating Interest Income / Expense
Net Income Before Taxes	38.8	-4.36	-4.68	-2.74	-2.08
Provision for Income Taxes
Net Income After Taxes	29.7	-3.72	-4.69	-2.05	-1.99
Net Income Before Extraordinary Items
Net Income	29.7	-3.72	-4.69	-2.05	-1.99
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	29.7	-3.72	-4.69	-2.05	-1.99
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	2.3	-0.289	-0.363	-0.159	-0.154
Dividends per Share